SBP solbec pharmaceuticals limited

progen granted orphan drug status

  1. keith bogucki
    40 Posts.
    clock Created with Sketch.
    04/05/04
    16:14
    Post #: 456790
    Progen (ASX:PGL) announced today that their lead anti-angiogenesis product (PI-88) has received Orphan Drug designation from the US FDA.

    Will be interesting to see the effect on Solbec & chances of gaining orphan drug status also.
    SBP Price at posting: 0.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RBD Restaurant Brands posts record sales in half year report for FY24
right-arrow Created with Sketch.
GBR Great Boulder hits fresh gold finds to the north of Mulga Bill in Meekatharra, WA
right-arrow Created with Sketch.
STX Strike hits "significant" 28m of net gas pay downhole Australia's deepest ever gas well; extends system east
right-arrow Created with Sketch.
NEWS Is the ASX getting its groove back? Here's 5 IPOs in September to watch
right-arrow Created with Sketch.
GED Golden Deeps sniffs 80-metre-long copper and zinc sulphide zone at NSW's Havilah
right-arrow Created with Sketch.
NEWS ASX explains: How 'futures' are predicted
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.